Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 6/20 | 0.59 |
| ▸ | CNR1 | P21554 | 4/20 | 0.59 |
| ▸ | CNR2 | P34972 | 4/20 | 0.59 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.50 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.50 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.50 |
| ▸ | CCR2 | P41597 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4139147 | 1.00 | TRPV1 (0.59) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL775913 | 0.89 | TRPV1 (0.69) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL777490 | 0.89 | TRPV1 (0.69) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL16001843 | 0.89 | TRPV1 (0.69) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL776984 | 0.87 | TRPV1 (0.66) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL776430 | 0.85 | TRPV1 (0.69) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL775515 | 0.85 | TRPV1 (0.69) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL13870525 | 0.85 | TRPV1 (0.69) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL13870526 | 0.85 | TRPV1 (0.69) | TRPV1CNR1CNR2GNAI3GNAO1 | |
| SCHEMBL19963564 | 0.85 | TRPV1 (0.69) | TRPV1CNR1CNR2GNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090192192-A1 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA | TOUCH BIONICS LIMITED (GB) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192192-A1 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA | PGLS, TFPI, Q6ZSR9 | TRPV1 462/4885CNR1 2563/4885CNR2 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.